Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
Cardiovascular Diseases (CVs) are one of the main causes of mortality and disability around the world. Advances in drug treatment have greatly improved survival and quality of life in the past decades, but associated adverse events remain a relevant problem. Pharmacogenetics can help individualize c...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ee9c57be612740ca8986a2041b14ae6c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|